Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children

Reported are 7 cases of posttransplant lymphoproliferative disorder (PTLD) arising in children who received umbilical cord blood transplantation (UCBT). There were 4 females and 3 males with a median age of 3 years (range, 1-16 years). All 7 patients received UCBT, including 1 patient who received m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgical pathology 2006-03, Vol.30 (3), p.328-336
Hauptverfasser: GONG, Jerald Z, BAYERL, Michael G, BUCKLEY, Patrick J, SANDHAUS, Linda M, SEBASTIAN, Siby, REHDER, Catherine W, ROUTBORT, Mark, LAGOO, Anand S, SZABOLCS, Paul, CHIU, Jeanie, COMITO, Melanie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 336
container_issue 3
container_start_page 328
container_title The American journal of surgical pathology
container_volume 30
creator GONG, Jerald Z
BAYERL, Michael G
BUCKLEY, Patrick J
SANDHAUS, Linda M
SEBASTIAN, Siby
REHDER, Catherine W
ROUTBORT, Mark
LAGOO, Anand S
SZABOLCS, Paul
CHIU, Jeanie
COMITO, Melanie
description Reported are 7 cases of posttransplant lymphoproliferative disorder (PTLD) arising in children who received umbilical cord blood transplantation (UCBT). There were 4 females and 3 males with a median age of 3 years (range, 1-16 years). All 7 patients received UCBT, including 1 patient who received multiple units and 1 transplanted under nonmyeloablative condition. The time interval from UCBT to PTLD averaged 4 months (range, 2 weeks to 9 months). Patients typically presented with high-stage disease with visceral organ involvement. Histology of the PTLDs showed monomorphic morphology in 5 cases and polymorphic morphology in the remaining 2 cases. Bone marrow biopsies were performed in 3 cases and were negative for PTLD. Epstein-Barr virus (EBV) was detected in the PTLD in all 7 patients by in situ hybridization. Evidence of past EBV infection was found in the recipients, but the EBV genome was not detected in the donor cord blood samples, suggesting that donor cord blood was not the source of EBV infection. The origin of the PTLD was investigated in 5 cases. PTLD was of host origin in 2 patients who failed engraftment and of donor origin in the remaining 3 patients who had complete engraftment. Four of 5 patients with monomorphic PTLD failed to demonstrate significant responses to rituximab and/or reduction of immunosuppression and died within 1 month after diagnosis. The remaining 2 patients with polymorphic PTLD showed complete response to therapy. One patient was alive 35 months after transplant, and the other patient died of infection 6 months after transplant. It is concluded that PTLD arising after UCBT in children occurs early after transplant and represents a serious EBV-related complication. PTLD may be of donor or recipient origin depending on engraftment status. Both monomorphic and polymorphic histology may be seen, and monomorphic histology appears to predict an unfavorable prognosis.
doi_str_mv 10.1097/01.pas.0000188030.63706.e7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67747233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67747233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-bf677b3f9e73c5695a929218f7ecdf1315c33ead7655fd126c19684ce895a3a3</originalsourceid><addsrcrecordid>eNpFkE1LxDAURYMoOo7-BSmC7lrzkuaj7kT8AkEX7kOaJhhJm5p0BP-9UQcmiwTCefddDkLngBvAnbjC0Mw6N7gckBJT3HAqMG-s2EMrYJTUher20QpDK2oGkh2h45w_Ck4kkEN0BJxRiRlZof415mVJespz0NNShe9xfo9zisE7m_Tiv2w1-BzTYFOl3VLuzdj74I0OlSnfVR9iHKpdRJmJU-Wnyrz7MCQ7naADp0O2p9t3jd7u795uH-vnl4en25vn2rRAl7p3XIieus4KahjvmO5IR0A6Yc3ggAIzlFo9CM6YG4BwAx2XrbGyoFTTNbr8jy3lPzc2L2r02dhQOtm4yaqkt4JQWsDrf9CkmHOyTs3Jjzp9K8DqV7DCoIpgtROs_gSr0myNzrZbNv1oh93o1mgBLraAzsWRK16MzztOcGgZkfQH3NiH1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67747233</pqid></control><display><type>article</type><title>Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>GONG, Jerald Z ; BAYERL, Michael G ; BUCKLEY, Patrick J ; SANDHAUS, Linda M ; SEBASTIAN, Siby ; REHDER, Catherine W ; ROUTBORT, Mark ; LAGOO, Anand S ; SZABOLCS, Paul ; CHIU, Jeanie ; COMITO, Melanie</creator><creatorcontrib>GONG, Jerald Z ; BAYERL, Michael G ; BUCKLEY, Patrick J ; SANDHAUS, Linda M ; SEBASTIAN, Siby ; REHDER, Catherine W ; ROUTBORT, Mark ; LAGOO, Anand S ; SZABOLCS, Paul ; CHIU, Jeanie ; COMITO, Melanie</creatorcontrib><description>Reported are 7 cases of posttransplant lymphoproliferative disorder (PTLD) arising in children who received umbilical cord blood transplantation (UCBT). There were 4 females and 3 males with a median age of 3 years (range, 1-16 years). All 7 patients received UCBT, including 1 patient who received multiple units and 1 transplanted under nonmyeloablative condition. The time interval from UCBT to PTLD averaged 4 months (range, 2 weeks to 9 months). Patients typically presented with high-stage disease with visceral organ involvement. Histology of the PTLDs showed monomorphic morphology in 5 cases and polymorphic morphology in the remaining 2 cases. Bone marrow biopsies were performed in 3 cases and were negative for PTLD. Epstein-Barr virus (EBV) was detected in the PTLD in all 7 patients by in situ hybridization. Evidence of past EBV infection was found in the recipients, but the EBV genome was not detected in the donor cord blood samples, suggesting that donor cord blood was not the source of EBV infection. The origin of the PTLD was investigated in 5 cases. PTLD was of host origin in 2 patients who failed engraftment and of donor origin in the remaining 3 patients who had complete engraftment. Four of 5 patients with monomorphic PTLD failed to demonstrate significant responses to rituximab and/or reduction of immunosuppression and died within 1 month after diagnosis. The remaining 2 patients with polymorphic PTLD showed complete response to therapy. One patient was alive 35 months after transplant, and the other patient died of infection 6 months after transplant. It is concluded that PTLD arising after UCBT in children occurs early after transplant and represents a serious EBV-related complication. PTLD may be of donor or recipient origin depending on engraftment status. Both monomorphic and polymorphic histology may be seen, and monomorphic histology appears to predict an unfavorable prognosis.</description><identifier>ISSN: 0147-5185</identifier><identifier>EISSN: 1532-0979</identifier><identifier>DOI: 10.1097/01.pas.0000188030.63706.e7</identifier><identifier>PMID: 16538052</identifier><identifier>CODEN: AJSPDX</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adolescent ; Biological and medical sciences ; Child ; Child, Preschool ; Cord Blood Stem Cell Transplantation - adverse effects ; Epstein-Barr Virus Infections - epidemiology ; Female ; Flow Cytometry ; Hematologic and hematopoietic diseases ; Herpesvirus 4, Human - isolation &amp; purification ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Infant ; Investigative techniques, diagnostic techniques (general aspects) ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoproliferative Disorders - etiology ; Lymphoproliferative Disorders - pathology ; Male ; Medical sciences ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Polymerase Chain Reaction ; Ribosomal Proteins - analysis ; RNA-Binding Proteins - analysis</subject><ispartof>The American journal of surgical pathology, 2006-03, Vol.30 (3), p.328-336</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-bf677b3f9e73c5695a929218f7ecdf1315c33ead7655fd126c19684ce895a3a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17614528$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16538052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GONG, Jerald Z</creatorcontrib><creatorcontrib>BAYERL, Michael G</creatorcontrib><creatorcontrib>BUCKLEY, Patrick J</creatorcontrib><creatorcontrib>SANDHAUS, Linda M</creatorcontrib><creatorcontrib>SEBASTIAN, Siby</creatorcontrib><creatorcontrib>REHDER, Catherine W</creatorcontrib><creatorcontrib>ROUTBORT, Mark</creatorcontrib><creatorcontrib>LAGOO, Anand S</creatorcontrib><creatorcontrib>SZABOLCS, Paul</creatorcontrib><creatorcontrib>CHIU, Jeanie</creatorcontrib><creatorcontrib>COMITO, Melanie</creatorcontrib><title>Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children</title><title>The American journal of surgical pathology</title><addtitle>Am J Surg Pathol</addtitle><description>Reported are 7 cases of posttransplant lymphoproliferative disorder (PTLD) arising in children who received umbilical cord blood transplantation (UCBT). There were 4 females and 3 males with a median age of 3 years (range, 1-16 years). All 7 patients received UCBT, including 1 patient who received multiple units and 1 transplanted under nonmyeloablative condition. The time interval from UCBT to PTLD averaged 4 months (range, 2 weeks to 9 months). Patients typically presented with high-stage disease with visceral organ involvement. Histology of the PTLDs showed monomorphic morphology in 5 cases and polymorphic morphology in the remaining 2 cases. Bone marrow biopsies were performed in 3 cases and were negative for PTLD. Epstein-Barr virus (EBV) was detected in the PTLD in all 7 patients by in situ hybridization. Evidence of past EBV infection was found in the recipients, but the EBV genome was not detected in the donor cord blood samples, suggesting that donor cord blood was not the source of EBV infection. The origin of the PTLD was investigated in 5 cases. PTLD was of host origin in 2 patients who failed engraftment and of donor origin in the remaining 3 patients who had complete engraftment. Four of 5 patients with monomorphic PTLD failed to demonstrate significant responses to rituximab and/or reduction of immunosuppression and died within 1 month after diagnosis. The remaining 2 patients with polymorphic PTLD showed complete response to therapy. One patient was alive 35 months after transplant, and the other patient died of infection 6 months after transplant. It is concluded that PTLD arising after UCBT in children occurs early after transplant and represents a serious EBV-related complication. PTLD may be of donor or recipient origin depending on engraftment status. Both monomorphic and polymorphic histology may be seen, and monomorphic histology appears to predict an unfavorable prognosis.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cord Blood Stem Cell Transplantation - adverse effects</subject><subject>Epstein-Barr Virus Infections - epidemiology</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Herpesvirus 4, Human - isolation &amp; purification</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Infant</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoproliferative Disorders - etiology</subject><subject>Lymphoproliferative Disorders - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Polymerase Chain Reaction</subject><subject>Ribosomal Proteins - analysis</subject><subject>RNA-Binding Proteins - analysis</subject><issn>0147-5185</issn><issn>1532-0979</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAURYMoOo7-BSmC7lrzkuaj7kT8AkEX7kOaJhhJm5p0BP-9UQcmiwTCefddDkLngBvAnbjC0Mw6N7gckBJT3HAqMG-s2EMrYJTUher20QpDK2oGkh2h45w_Ck4kkEN0BJxRiRlZof415mVJespz0NNShe9xfo9zisE7m_Tiv2w1-BzTYFOl3VLuzdj74I0OlSnfVR9iHKpdRJmJU-Wnyrz7MCQ7naADp0O2p9t3jd7u795uH-vnl4en25vn2rRAl7p3XIieus4KahjvmO5IR0A6Yc3ggAIzlFo9CM6YG4BwAx2XrbGyoFTTNbr8jy3lPzc2L2r02dhQOtm4yaqkt4JQWsDrf9CkmHOyTs3Jjzp9K8DqV7DCoIpgtROs_gSr0myNzrZbNv1oh93o1mgBLraAzsWRK16MzztOcGgZkfQH3NiH1Q</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>GONG, Jerald Z</creator><creator>BAYERL, Michael G</creator><creator>BUCKLEY, Patrick J</creator><creator>SANDHAUS, Linda M</creator><creator>SEBASTIAN, Siby</creator><creator>REHDER, Catherine W</creator><creator>ROUTBORT, Mark</creator><creator>LAGOO, Anand S</creator><creator>SZABOLCS, Paul</creator><creator>CHIU, Jeanie</creator><creator>COMITO, Melanie</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children</title><author>GONG, Jerald Z ; BAYERL, Michael G ; BUCKLEY, Patrick J ; SANDHAUS, Linda M ; SEBASTIAN, Siby ; REHDER, Catherine W ; ROUTBORT, Mark ; LAGOO, Anand S ; SZABOLCS, Paul ; CHIU, Jeanie ; COMITO, Melanie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-bf677b3f9e73c5695a929218f7ecdf1315c33ead7655fd126c19684ce895a3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cord Blood Stem Cell Transplantation - adverse effects</topic><topic>Epstein-Barr Virus Infections - epidemiology</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Herpesvirus 4, Human - isolation &amp; purification</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Infant</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoproliferative Disorders - etiology</topic><topic>Lymphoproliferative Disorders - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Polymerase Chain Reaction</topic><topic>Ribosomal Proteins - analysis</topic><topic>RNA-Binding Proteins - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GONG, Jerald Z</creatorcontrib><creatorcontrib>BAYERL, Michael G</creatorcontrib><creatorcontrib>BUCKLEY, Patrick J</creatorcontrib><creatorcontrib>SANDHAUS, Linda M</creatorcontrib><creatorcontrib>SEBASTIAN, Siby</creatorcontrib><creatorcontrib>REHDER, Catherine W</creatorcontrib><creatorcontrib>ROUTBORT, Mark</creatorcontrib><creatorcontrib>LAGOO, Anand S</creatorcontrib><creatorcontrib>SZABOLCS, Paul</creatorcontrib><creatorcontrib>CHIU, Jeanie</creatorcontrib><creatorcontrib>COMITO, Melanie</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GONG, Jerald Z</au><au>BAYERL, Michael G</au><au>BUCKLEY, Patrick J</au><au>SANDHAUS, Linda M</au><au>SEBASTIAN, Siby</au><au>REHDER, Catherine W</au><au>ROUTBORT, Mark</au><au>LAGOO, Anand S</au><au>SZABOLCS, Paul</au><au>CHIU, Jeanie</au><au>COMITO, Melanie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children</atitle><jtitle>The American journal of surgical pathology</jtitle><addtitle>Am J Surg Pathol</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>30</volume><issue>3</issue><spage>328</spage><epage>336</epage><pages>328-336</pages><issn>0147-5185</issn><eissn>1532-0979</eissn><coden>AJSPDX</coden><abstract>Reported are 7 cases of posttransplant lymphoproliferative disorder (PTLD) arising in children who received umbilical cord blood transplantation (UCBT). There were 4 females and 3 males with a median age of 3 years (range, 1-16 years). All 7 patients received UCBT, including 1 patient who received multiple units and 1 transplanted under nonmyeloablative condition. The time interval from UCBT to PTLD averaged 4 months (range, 2 weeks to 9 months). Patients typically presented with high-stage disease with visceral organ involvement. Histology of the PTLDs showed monomorphic morphology in 5 cases and polymorphic morphology in the remaining 2 cases. Bone marrow biopsies were performed in 3 cases and were negative for PTLD. Epstein-Barr virus (EBV) was detected in the PTLD in all 7 patients by in situ hybridization. Evidence of past EBV infection was found in the recipients, but the EBV genome was not detected in the donor cord blood samples, suggesting that donor cord blood was not the source of EBV infection. The origin of the PTLD was investigated in 5 cases. PTLD was of host origin in 2 patients who failed engraftment and of donor origin in the remaining 3 patients who had complete engraftment. Four of 5 patients with monomorphic PTLD failed to demonstrate significant responses to rituximab and/or reduction of immunosuppression and died within 1 month after diagnosis. The remaining 2 patients with polymorphic PTLD showed complete response to therapy. One patient was alive 35 months after transplant, and the other patient died of infection 6 months after transplant. It is concluded that PTLD arising after UCBT in children occurs early after transplant and represents a serious EBV-related complication. PTLD may be of donor or recipient origin depending on engraftment status. Both monomorphic and polymorphic histology may be seen, and monomorphic histology appears to predict an unfavorable prognosis.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>16538052</pmid><doi>10.1097/01.pas.0000188030.63706.e7</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0147-5185
ispartof The American journal of surgical pathology, 2006-03, Vol.30 (3), p.328-336
issn 0147-5185
1532-0979
language eng
recordid cdi_proquest_miscellaneous_67747233
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Biological and medical sciences
Child
Child, Preschool
Cord Blood Stem Cell Transplantation - adverse effects
Epstein-Barr Virus Infections - epidemiology
Female
Flow Cytometry
Hematologic and hematopoietic diseases
Herpesvirus 4, Human - isolation & purification
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Infant
Investigative techniques, diagnostic techniques (general aspects)
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoproliferative Disorders - etiology
Lymphoproliferative Disorders - pathology
Male
Medical sciences
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Polymerase Chain Reaction
Ribosomal Proteins - analysis
RNA-Binding Proteins - analysis
title Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T18%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Posttransplant%20lymphoproliferative%20disorder%20after%20umbilical%20cord%20blood%20transplantation%20in%20children&rft.jtitle=The%20American%20journal%20of%20surgical%20pathology&rft.au=GONG,%20Jerald%20Z&rft.date=2006-03-01&rft.volume=30&rft.issue=3&rft.spage=328&rft.epage=336&rft.pages=328-336&rft.issn=0147-5185&rft.eissn=1532-0979&rft.coden=AJSPDX&rft_id=info:doi/10.1097/01.pas.0000188030.63706.e7&rft_dat=%3Cproquest_cross%3E67747233%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67747233&rft_id=info:pmid/16538052&rfr_iscdi=true